
zzso is a zzso zzso zzso with active oral and intravenous zzso The effects of this class are enhanced when combined with zzso This study tested the ability of the combination of oral zzso 200 zzso and oral zzso 20 zzso to prevent acute zzso in cancer patients receiving initial zzso at doses zzso or zzso 70 zzso Additionally, patients were randomly assigned to receive a second dosage of the regimen 16 hours later to improve control of acute zzso 

A total of 75 patients were entered, with 38 zzso to the zzso zzso Thirty-five percent were women and zzso had lung zzso 

Overall, the regimen prevented acute vomiting in zzso zzso confidence zzso zzso to zzso including zzso of 35 patients who received zzso at doses zzso or zzso 100 zzso There was no observed difference in zzso prevention between the zzso zzso and zzso zzso regimens zzso confidence zzso for the difference, zzso to zzso The median time to the onset of zzso was 19 hours for the zzso regimen and 17 hours for the zzso regimen in those patients with zzso zzso occurred in zzso who received one dose and zzso who received two zzso 

The combination of oral zzso 200 zzso and zzso 20 zzso given only once prevented acute zzso in zzso of patients who received zzso zzso or zzso 70 zzso Administration of a second dose of the regimen did not improve the observed prevention rate or delay the time to zzso This zzso oral regimen has comparable or better effectiveness than reported results of intravenous combination regimens in preventing zzso vomiting and merits further study and zzso 

